Intralipid Reduces Toxicity of Chemotherapy Nanodrug (IMAGE)

Carnegie Mellon University

Intralipid Reduces Toxicity of Chemotherapy Nanodrug

Caption

Administering a combination of Abraxane® and Intralipid® results in less of toxicity of the chemotherapy drug in the kidney (bottom row) than administering Abraxane® alone (top row).

Credit

Carnegie Mellon University

Usage Restrictions

Credit: Carnegie Mellon University

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.